A Study of Effects of Itraconazole and Rifampin on Selpercatinib (LY3527723) in Healthy Participants
Status:
Completed
Trial end date:
2018-08-22
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the effect of itraconazole and rifampin on how
fast selpercatinib gets into the blood stream and how long it takes the body to remove it
when administered in healthy participants. Information about safety and tolerability will be
collected. The study is conducted in two parts and it will last up to 54 days (part 1) and 59
days (part 2), respectively, inclusive of screening period.